Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn's disease after ileocecal resection results in prolonged continuation as compared to anti-tumor necrosis factor monotherapy

Autor: Sebastiaan, Ten Bokkel Huinink, Evelien M J, Beelen, Thomas, Ten Bokkel Huinink, Frank, Hoentjen, Alexander, G L Bodelier, Gerard, Dijkstra, Marielle, Romberg-Camps, Nanne K, de Boer, Laurents P S, Stassen, Andrea E, van der Meulen, Rachel, West, Oddeke, van Ruler, C Janneke, van der Woude, Annemarie C, de Vries

Publikováno v: European journal of gastroenterologyhepatology. 35(1)

A considerable proportion of Crohn's disease patients that undergo ileocecal resection (ICR) have failed anti-tumor necrosis factor (TNF) therapy preoperatively. This study aimed to assess the effectiveness of retreatment of anti-TNF therapy in patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7256e2a2113c66b3fe79c389182af153
https://pubmed.ncbi.nlm.nih.gov/36468568

The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients

Autor: Lennard P L Gilissen, Alette Daniels, Dennis R Wong, Marielle Romberg, Arnold Stronkhorst, Ad A. van Bodegraven, Rudaba Tajzai, Marieke Pierik, Karin Steenhuisen

Publikováno v: European Journal of Gastroenterology & Hepatology, 33(1S Suppl 1), e102-e107. LIPPINCOTT WILLIAMS & WILKINS
Gilissen, L P L, Tajzai, R, Romberg, M, Pierik, M, Stronkhorst, A, Steenhuisen, K, van Bodegraven, A, Daniels, A & Wong, D 2021, ' The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients ', European journal of gastroenterology & hepatology, vol. 33, no. 1S Suppl 1, pp. e102-e107 . https://doi.org/10.1097/MEG.0000000000001980
European journal of gastroenterology & hepatology, 33(1S Suppl 1), e102-e107. Lippincott Williams and Wilkins

INTRODUCTION: Nodular regenerative hyperplasia (NRH) has been associated with thiopurine therapy in patients with inflammatory bowel disease (IBD), but prevalence and prognosis of NRH remain unclear. This study is a cross-sectional search for NRH in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::530594c60602cd77b8d52d856d5db7e2
https://pubmed.ncbi.nlm.nih.gov/33136726

Extensive forearm deep venous thrombosis following a severe infliximab infusion reaction

Autor: Marielle Romberg, Barbara Ryan, Reinhold W. Stockbrügger, Frank Wolters

Publikováno v: European Journal of Gastroenterology & Hepatology, 16(9), 941-2. LIPPINCOTT WILLIAMS & WILKINS

Here we describe a patient with Crohn's disease who developed a severe infliximab infusion reaction (IIR), complicated 1 day later by severe swelling of the forearm and hand ipsilateral to the site of infliximab infusion. This proved to be extensive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a12789ba91729cf6306b33094f6e3572
https://doi.org/10.1097/00042737-200409000-00022

Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial

Autor: Lloyd Brandts, M Pierik, Manuela Joore, Laura Janssen, Mariëlle Romberg-Camps, Ad van Bodegraven, Jeoffrey Haans, Michèl Aquarius, Paul Boekema, Tamara Munnecom, Adrian Masclee, D Jonkers

Publikováno v: BMJ Open, Vol 11, Iss 5 (2021)

Introduction Crohn’s disease (CD) is a chronic inflammatory bowel disease with a heterogeneous clinical presentation, relapse rate and treatment response. At present, no markers are available to adequately predict disease course at diagnosis. To pr

Externí odkaz: https://doaj.org/article/54447b8c1ec542b096067a58b283a0d0